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Objectives This study sought to identify risk factors for the occurrence of all-cause hospital admissions among older per-
sons after heart failure diagnosis, and to determine whether geriatric conditions would emerge as independent
risk factors for admission when evaluated in the context of other relevant clinical data.
Background Efforts to reduce costs in heart failure have focused on hospital utilization, yet few studies have examined how geriat-
ric conditions affect the long-term risk for hospital admission after heart failure diagnosis. With the aging of the popula-
tion with heart failure, geriatric conditions such as slow gait and muscle weakness are becoming increasingly common.
Methods The study population included participants with a new diagnosis of heart failure in the Cardiovascular Health
Study, a longitudinal study of community-living older persons. Data were collected through annual examinations
and medical-record reviews. Geriatric conditions assessed were slow gait, muscle weakness (defined as weak
grip), cognitive impairment, and depressive symptoms. Anderson-Gill regression modeling was used to deter-
mine the predictors of hospital admission after heart failure diagnosis.
Results Of the 758 participants with a new diagnosis of heart failure, the mean rate of hospital admission was 7.9 per 10 person-
years (95% CI: 7.4 to 8.4). Independent risk factors for hospital admission included diabetes mellitus (HR: 1.36; 95% CI:
1.13 to 1.64), New York Heart Association functional class III or IV (HR: 1.32; 95% CI: 1.11 to 1.57), chronic kidney disease
(HR: 1.32; 95% CI: 1.14 to 1.53), slow gait (HR: 1.28; 95% CI: 1.06 to 1.55), depressed ejection fraction (HR: 1.25; 95% CI:
1.04 to 1.51), depression (HR: 1.23; 95% CI: 1.05 to 1.45), and muscle weakness (HR: 1.19; 95% CI: 1.00 to 1.42).
Conclusions Geriatric conditions are important, and potentially modifiable, risk factors for hospital admission in heart failure
that should be routinely assessed at the time of heart failure diagnosis. (J Am Coll Cardiol 2013;61:635–42)
© 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.11.027As the population has aged and survival with cardiovascular
disease has increased, the number of older persons with
heart failure has increased considerably over the past 20
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Hospital Admission in Heart Failure February 12, 2013:635–42older (2). Costs associated with
heart failure exceed $35 billion
annually in the United States and
are largely driven by hospital
stays (3), yet relatively little is
known about the long-term risk
for hospital admission after heart
failure diagnosis in older persons.
Most studies have focused on the
short-term (i.e., 30 days to 1
year) risk for hospital readmis-
sion after an initial hospital admis-
sion for heart failure. However,
these short-term risk models have
not fully characterized cumulative,
lifetime hospital utilization after
heart failure diagnosis, which is rel-
evant from a public health perspective. Heart failure in older
persons is often marked by recurrent episodes of clinical decom-
pensation necessitating multiple hospital admissions. Further-
more, whereas geriatric conditions such as slow gait, muscle
weakness, and cognitive impairment are emerging as im-
portant predictors of outcomes among older persons with
cardiovascular disease (4–6), information about these con-
ditions is not available in most heart failure registries, and
their prognostic relevance for hospital admission in older
patients with heart failure remains unclear.
To address these gaps in knowledge, the present study
evaluated data from a population-based sample of persons
age 65 years or older, with a follow-up period of up to 20
years after heart failure diagnosis. These data included a rich
array of information, such as clinical heart failure assess-
ments, laboratory evaluations, comorbid diseases, and ob-
jective assessments of several geriatric conditions. The goals
were to identify risk factors for all-cause hospital admission
among older persons after a new diagnosis of heart failure
and to determine whether geriatric conditions would
emerge as independent risk factors for admission when
evaluated in the context of other relevant clinical data. This
prognostic information may be used to assist in clinical
decision making and to identify potential targets for inter-
vention after heart failure diagnosis in older persons.
Methods
Study Population
The study population included Cardiovascular Health Study
(CHS) participants with heart failure diagnosed after CHS
enrollment. The objective of CHS was to identify factors
associated with the onset of cardiovascular disease in older
persons; however, potentially eligible participants with car-
diovascular disease at the CHS screening visit were in-
cluded. In 1989, 5,201 men and women age 65 years or
older were enrolled into CHS from 4 communities across
the United States, with an additional 687 African Ameri-
Abbreviations
and Acronyms
3MS  Modified Mini-
Mental State Examination
ACE  angiotensin-
converting enzyme
BMI  body mass index
CAD  coronary artery
disease
CHS  Cardiovascular
Health Study
DSST  Digit Symbol
Substitution Test
NYHA  New York Heart
Associationcans recruited in 1992 to enhance minority representation.Potential CHS participants were identified from Medicare-
eligibility lists. Persons who were wheelchair bound or
receiving cancer or hospice treatment were excluded from
CHS. Complete details on the inclusion/exclusion criteria
have been previously reported (7).
Data Collection
In CHS, data about the development of heart failure and
potential risk factors for hospital admission were collected
every 12 months from 1989 to 1999 through in-person
interviews and examinations, and hospital admissions
through 2009 were ascertained. According to the CHS
protocol, potential cases of incident heart failure were
identified through 2 mechanisms: 1) hospital admission for
heart failure, representing 85% of the new heart failure cases
included in these analyses; and 2) self-report of a physician’s
diagnosis of heart failure (8). CHS criteria for heart failure
required that a participant have a diagnosis of heart failure
from a physician and be receiving medical treatment (e.g., a
diuretic agent, an angiotensin-converting enzyme [ACE]
inhibitor, or digitalis) for heart failure. The presence of
cardiomegaly and pulmonary edema on chest x-ray, or
evidence of left ventricular dysfunction by echocardiography
or ventriculography, was used to support the diagnosis of
heart failure. All potential cases of heart failure were
adjudicated by an expert panel that reviewed all pertinent
data from medical records. Participants entered the analysis
at the time of the CHS study assessment (hereafter referred
to as baseline) immediately after their heart failure diagnosis.
However, because the objective of the present study was to
identify risk factors for hospital admission that were present
at the time of heart failure diagnosis, and because of the
uncertainty about the duration of heart failure among
prevalent cases in CHS, data from 275 CHS participants
who had heart failure at the time of CHS enrollment were
excluded from the present analysis.
Study Variables
Potential risk factors. DEMOGRAPHICS. Age was consid-
ered in 10-year categories. Sex, race (nonwhite vs. white),
and highest level of education (12th grade vs. 12th grade
or higher) were also included in the analyses.
HEART FAILURE STATUS. Ejection fraction was classified as
epressed (45%) or preserved (45%) based on clinical
studies of left ventricular function (echocardiography, nu-
clear, or catheterization data) performed at the time of
hospital admission for heart failure diagnosis. New York
Heart Association (NYHA) classification was ascertained
through information obtained in participant interviews.
ACE inhibitor and beta-blocker use was ascertained
through participants’ self-report and a medical record
review.
BODY MASS INDEX. Based on previous work demonstrating
associations of body mass index (BMI) with heart failure
outcomes (9), BMI categories were selected to represent low
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February 12, 2013:635–42 Hospital Admission in Heart Failurebody weight (18 kg/m2), normal body weight (18 to 24.9
g/m2), overweight (25 to 29.9 kg/m2), and obesity (30
g/m2), using data obtained from physical examinations.
COMORBID DISEASES. Comorbid diseases were assessed ac-
ording to CHS protocol (10) and included diabetes melli-
us, chronic kidney disease, chronic obstructive pulmonary
isease, coronary artery disease (CAD), stroke, and anemia.
articipants were considered diabetic if they reported a
hysician’s diagnosis of diabetes mellitus, had a fasting
erum glucose concentration of 126 mg/dl, had a serum
lucose concentration of at least 200 mg/dl at 2 h on oral
lucose tolerance test, or reported use of antidiabetic med-
cations. Chronic kidney disease was ascertained through
aboratory evaluation, with calculation of glomerular filtra-
ion rate, with a cutoff point of 60 ml/min. Chronic
bstructive pulmonary disease was ascertained through self-
eport of a physician’s diagnosis. Discharge summaries,
edication use, cardiac enzyme levels, electrocardiograms,
nd brain imaging were reviewed by the CHS Cardiovas-
ular Events Committee to classify all potential cases of
AD and stroke. The presence of anemia was ascertained
hrough laboratory evaluation. A hemoglobin concentration
utoff point of 12 g/dl was used to indicate anemia in
omen, and a cutoff point of 13 g/dl was used in men.
GERIATRIC CONDITIONS. Geriatric conditions were defined as
hose that occur in older adults and that are typically
ultifactorial in etiology but not necessarily related to a
pecific disease (11). The 4 geriatric conditions assessed
ere impairments in muscle strength, gait speed, cognitive
unction, and psychological status. Geriatric conditions
ere classified as present or absent, as follows. Grip
trength, an indicator of overall muscle strength (12), was
easured in the dominant hand using a handheld dyna-
ometer (13). Weak grip was defined as 28.5 kg in men
nd 18.5 kg in women (14). Gait speed was assessed by
ecording the time required to walk 15 feet at usual pace,
nd slow gait was defined as a gait speed of 0.8 m/s (15).
ognitive function was measured using the Modified Mini-
ental State Examination (3MS) (16) and the Digit
ymbol Substitution Test (DSST) (17). The 3MS is an
xpanded version of the Folstein Mini-Mental State Exam-
nation, a widely used screening test for dementia (18). The
SST assesses several cognitive processes, including visual
earch, visual–motor coordination, and cognitive flexibility.
s in previous CHS work (19), cognitive impairment was
efined as a score 80 on the 3MS or a score 19 (which
epresents 1.5 SDs below the mean score for this age group)
n the DSST. Depression was classified as a score of at least
on the (short-form) Center for Epidemiologic Studies–
epression scale (20), a self-reported measure of depressive
ymptoms experienced during the previous week.
ll-cause hospital admissions. At the annual contacts,
articipants were asked about major illnesses and hospital
dmissions. Medical records were obtained for all reported
ospital admissions. Medicare-utilization files were wearched to ascertain hospital admissions that may have
een missed. These procedures have been used in prior
HS work to ascertain hospital utilization (21). If the
iagnosis of heart failure was made during a hospital stay,
ata from that event were not included in the outcome, as
he present study evaluated the risk for hospital admission
fter heart failure was diagnosed.
tatistical Analysis
haracteristics of the study population at the time of heart
ailure diagnosis were described, and Anderson-Gill regres-
ion modeling (22) was used to evaluate the associations
etween the potential baseline risk factors and hospital
dmission. This technique allowed all hospital admissions
o have been analyzed, in contrast to Cox modeling, which
ould have considered only the first admission. With the
xception of age and sex, which were retained in the final
odels, factors were selected according to a hierarchical
creening process to create a parsimonious, multivariate
odel (23). First, bivariate association between each factor
nd the outcome was evaluated. Only variables with a p
alue 0.30 were considered further. Next, the correlations
mong the remaining factors were sequentially evaluated
ith the Kendall correlation coefficient. Those with a
orrelation coefficient 0.3 may have resulted in collinear-
ty; thus, a single risk factor was retained on the basis of
linical judgment and the strength of the association with
he outcome. A backward selection method was used to
valuate the impact of each of the remaining risk factors on
he overall model fit through a series of Anderson-Gill
odels. To assess each factor’s contribution to the model fit,
chi-square distribution was used, with degrees of freedom
qualing the number of parameters for the added factor, on
he basis of the difference in the 2 log likelihood (LL)
tatistics between the models with and without the factor.
fter a separate model was fitted for each factor, the factor
ith the largest difference in 2 LL was added to the
verall model. This process was continued iteratively until
o factor significantly increased the model fit based on the
2 LL criterion. Participants were censored at the time of
eath. In supplementary analyses, the combined endpoint
ll-cause hospital admission or death was considered, using
he same approach described for the endpoint all-cause
ospital admission alone. To provide further understanding
f the clinical impact of the independent risk factors,
ospital admission rates (per 10 person-years) were calcu-
ated with and without each of the factors.
Risk-factor data that were missing from the baseline
valuation (i.e., at the CHS study visit immediately after
eart failure diagnosis) were “carried forward” from the last
vailable assessment (i.e., last observation carried forward
LOCF]). For ejection fraction, NYHA classification, and
eart failure medication (ACE inhibitor and beta-blocker)
se, the LOCF approach was not used because those values
ould have been expected to have changed substantially at
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Hospital Admission in Heart Failure February 12, 2013:635–42the time of heart failure diagnosis. For those variables,
missing values were retained as distinct categories.
All statistical tests were 2-tailed, and p  0.05 was
onsidered to have indicated statistical significance. All
nalyses were conducted using SAS software version 9.2
SAS Institute Inc., Cary, North Carolina).
esults
tudy Population
uring the study period, 758 CHS participants were newly
iagnosed with heart failure and were included in the
resent analysis. As shown in Table 1, the mean age at the
ime of heart failure diagnosis was 79.7 years. Most partic-
pants were white, about one-third had a 12th-grade
ducation, and nearly one-fifth were obese. The majority of
Baseline Demographic and ClinicalCharacteristics of t e Study Patients (N  758)Table 1 Baseline Demographic and ClinicalCharacteristics of the Study Patients (N  758)
Age, yrs 79.7 6.2
Age group
65–75 yrs 170 (22.4)
75–85 yrs 417 (55.0)
85 yrs 171 (22.6)
Female 383 (50.5)
Nonwhite race 97 (12.8)
Education  high school 270 (35.8)
BMI group
18 kg/m2 23 (3.0)
18–25 kg/m2 329 (43.5)
25–30 kg/m2 270 (35.7)
30 kg/m2 135 (17.8)
Heart failure status
Ejection fraction 45% 203 (43.2)
NYHA functional class
I 22 (3.2)
II 462 (66.5)
III 173 (24.9)
IV 38 (5.4)
ACE inhibitor use 257 (40.7)
Beta-blocker use 99 (15.7)
Comorbid conditions
Coronary artery disease 463 (61.1)
Chronic kidney disease 280 (37.1)
Diabetes mellitus 193 (25.5)
Stroke 125 (16.5)
COPD 112 (14.8)
Anemia 111 (14.7)
Geriatric conditions
Slow gait 317 (41.8)
Weak grip 317 (41.8)
Depression 296 (39.1)
Cognitive impairment 264 (34.8)
Values are mean  SD or n (%). All missing data 1%, with the exceptions of ejection fraction
37.9%), NYHA class (8.3%), and ACE inhibitors and beta-blockers (16.6% each). Percentages were
alculated based on participants without missing data.
ACE  angiotensin-converting enzyme; BMI  body mass index; COPD  chronic obstructive
ulmonary disease; NYHA  New York Heart Association.he cohort had preserved ejection fraction, and 30.3% wereNYHA functional class III or IV. ACE inhibitors were
being used in 40.7% of participants, and beta-blockers, in
15.7%. As would be expected in a heart failure cohort, CAD
was the most common comorbid condition, followed by
chronic kidney disease and diabetes mellitus. Geriatric
conditions were common, with muscle weakness, slow gait,
cognitive impairment, and depression all present in approx-
imately 40% of the cohort. (In comparison, at the time of
enrollment into CHS, the mean age of the study partici-
pants [N  5,888] was 72 years, and 57.6% were female.
AD was present in 19.4% and 22.8% of patients were
iabetic and 4.2% had a history of stroke. Muscle weakness
as present in 20% of participants; slow gait, in 22.1%;
ognitive impairment, in 13.2%; and depression, in 21.5%.)
ospital admission after heart failure diagnosis. A total
of 2,395 hospital admissions occurred during a median
follow-up of 3.4 years (IQR: 1.8 to 5.9 years). By the end of
the follow-up period (2009), 75% of the participants had
died. As shown in Figure 1, the number of hospital
admissions per participant ranged from 0 (in 14% of the
cohort) to 56, with the median of 3.4 (IQR: 1.8 to 5.9). The
mean rate of hospital admission was 7.9 per 10 person-years
(95% CI: 7.4– to 8.4). Among participants with preserved
ejection fraction, the rate of hospital admissions was some-
what lower, 7.0 per 10 person-years (95% CI: 6.6 to 7.4).
Hospital admission and mortality over the study period.
Shown in Table 2 are hospital-admission and mortality rates
over the 20-year study period. The group whose heart
failure was diagnosed between 1990 and 1994 had a greater
rate of hospital admissions across the study period compared
with the group whose heart failure was diagnosed between
1995 and 1999 (p 0.001). The rate of hospital admissions
(among all participants) was generally stable across the
follow-up period, with an increase in years 6 to 10 compared
with years 1 to 5 and then a decrease in years 11 to 20. The
mortality rate was slightly higher in the group whose heart
failure was diagnosed between 1995 and 1999 than in the
Figure 1 Median Number of Hospital Admissions
Per Person After Heart Failure Diagnosis
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February 12, 2013:635–42 Hospital Admission in Heart Failuregroup whose heart failure was diagnosed between 1990 and
1994, but these differences achieved statistical significance
only at years 1 to 5. As would be expected, the overall
mortality rate increased over the study period (p  0.001).
Risk factors for hospital admission after heart failure
diagnosis. As shown in Table 3, several characteristics
were associated with hospital admission on bivariate
analysis. Race, BMI, ACE inhibitor use, and CAD did
not meet the bivariate p value criterion (p  0.30) and
were not considered further. None of the potential risk
factors were excluded because of collinearity. On multi-
variate analysis, independent risk factors for hospital
admission were diabetes mellitus (HR: 1.36; 95% CI:
Hospital Admission and Mortality Rates (95% CI) After Heart FailurTable 2 Hospital Admission and Mortality Rates (95% CI) After
Year at
Diagnosis
1–5 Yrs After Diagnosis 6
n* Hospital Admission, % Mortality, % n* Hos
1990–1994 283 7.9 (7.4–8.4) 1.3 (1.1–1.5) 144 1
1995–1999 475 7.4 (7.0–7.9) 1.5 (1.4–1.8) 141
Total 758 7.6 (7.3–8.0) 1.4 (1.3–1.4) 285
*Number of participants at the beginning of the time period.
Risk For All-Cause Hospital Admission, by BaseTable 3 Risk For All-Cause Hospital Admiss
Characteristic
Bivariate
Hazard Ratio (95% C
Age group
65–75 yrs Reference
75–85 yrs 1.05 (0.86 to1.28
85 yrs 1.33 (1.04 to1.71
Female 0.98 (0.83 to1.14
Nonwhite race 1.09 (0.86 to1.39
Education 12th grade 1.18 (1.00 to1.40
BMI group
18 kg/m2 1.17 (0.76 to1.81
18–25 kg/m2 Reference
25–30 kg/m2 0.93 (0.78 to1.10
30 kg/m2 1.05 (0.83 to1.34
Heart failure status
Ejection fraction 45% 1.32 (1.07 to1.62
NYHA functional class III/IV 1.37 (1.14 to1.65
Not taking ACE inhibitor 1.05 (0.87 to1.27
Not taking beta-blocker 1.23 (0.98 to1.55
Comorbid conditions
Diabetes mellitus 1.42 (1.17 to1.74
Chronic kidney disease 1.31 (1.11 to 1.55)
Stroke 1.27 (1.03 to1.56
COPD 1.16 (0.94 to1.44
Anemia 1.16 (0.92 to1.45
Coronary artery disease 1.09 (0.92 to 1.29)
Geriatric conditions
Slow gait 1.49 (1.24 to1.80
Cognitive impairment 1.33 (1.14 to1.56
Depression 1.33 (1.13 to1.56
Weak grip 1.21 (1.02 to 1.44)*Model is adjusted for year of heart failure diagnosis (1990 to 1999).
Abbreviations as in Table 1.1.13 to 1.64), NYHA class III or IV (HR: 1.32; 95% CI:
1.11 to 1.57), chronic kidney disease (HR: 1.32; 95% CI:
1.14 to 1.53), slow gait (HR: 1.28; 95% CI: 1.06 to 1.55),
depressed ejection fraction (HR: 1.25; 95% CI: 1.04 to
1.51), depression (HR: 1.23; 95% CI: 1.05 to 1.45), and
muscle weakness (HR: 1.19; 95% CI: 1.00 to 1.42).
Missing categories of ejection fraction, NYHA, ACE
inhibitor use, and beta-blocker use were not significantly
associated with hospital admission.
Hospital admission rates (per 10 person-years) with and
without each of the independent risk factors are shown in
Figure 2. The presence of depression was associated with a
23% increase in hospital admission rate (i.e., the group without
gnosis per 10 Person-Yearsrt Failure Diagnosis per 10 Person-Years
rs After Diagnosis 11–20 Yrs After Diagnosis
dmission, % Mortality, % n* Hospital Admission, % Mortality, %
.3–11.0) 1.7 (1.4–2.1) 60 7.7 (6.5–9.0) 2.2 (1.7–3.0)
.6–8.4) 1.9 (1.5–2.4) 25 6.0 (3.4–10.5) 2.5 (1.0–6.0)
.4–9.7) 1.8 (1.5–2.1) 85 7.5 (6.4–8.8) 2.3 (1.7–3.0)
haracteristicy Baseline Characteristic
Multivariate Model*
p Value Hazard Ratio (95% CI) p Value
Reference
0.666 0.96 (0.81 to 1.15) 0.655
0.022 1.20 (0.94 to 1.53) 0.139
0.765 0.89 (0.77 to 1.03) 0.124
0.475 — —
0.048 1.12 (0.96 to 1.31) 0.146
0.470 — —
— —
0.393 — —
0.675 — —
0.010 1.25 (1.04 to 1.51) 0.019
0.001 1.32 (1.11 to 1.57) 0.001
0.616 — —
0.076 1.21 (0.99 to 1.46) 0.059
0.001 1.36 (1.13 to 1.64) 0.001
0.002 1.32 (1.14 to 1.53) 0.001
0.024 1.15 (0.95 to 1.38) 0.149
0.164 — —
0.210 — —
0.317 — —
0.001 1.28 (1.06 to 1.55) 0.010
0.001 — —
0.001 1.23 (1.05 to 1.43) 0.010
0.030 1.19 (1.00 to 1.42) 0.050e DiaHea
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Hospital Admission in Heart Failure February 12, 2013:635–42depression had 7.13 hospital admissions per 10 person-years
compared to 9.26 in the group with depression). Similarly,
slow gait was associated with a 30% increase in hospital
admission rate, and muscle weakness, with a 16% increase. The
presence of diabetes mellitus was associated with a 29%
increase; chronic kidney disease, with a 22% increase; de-
pressed ejection fraction, with a 25% increase; and NYHA
functional class III or IV, with a 27% increase.
Results from analyses that considered hospital admission or
death as a composite endpoint were similar to those from
analyses that considered hospital admission alone. On multi-
variate analysis, diabetes mellitus (HR: 1.36; 95% CI: 1.13 to
1.63), chronic kidney disease (HR: 1.33; 95% CI: 1.15 to
1.53), NYHA class III or IV (HR: 1.32; 95% CI: 1.12 to 1.57),
depressed ejection fraction (HR: 1.26; 95% CI: 1.04 to 1.51),
slow gait (HR: 1.31; 95% CI: 1.08 to 1.58), depression (HR:
1.22; 95% CI: 1.05 to 1.43), and muscle weakness (HR: 1.19;
95% CI: 1.00 to 1.42) were independently associated with
hospital admission or mortality.
Discussion
In this cohort of community-living older persons, 3 geriatric
conditions, namely muscle weakness, slow gait, and depres-
sion, emerged as independent risk factors for hospital
admission after heart failure diagnosis, even when other
relevant demographic, social, and clinical factors were con-
sidered. Other independent risk factors included depressed
ejection fraction, NYHA class III or IV, diabetes mellitus,
No Yes No Yes No Yes
0
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15
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Ejection
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Figure 2 Rates of Hospital Admission Per 10 Person-Years, Wi
Bars represent 95% confidence intervals.and chronic kidney disease.Why would these geriatric conditions predict hospital
utilization among older persons with newly diagnosed heart
failure? In the case of slow gait, walking places demands on
multiple organ systems, including the cardiovascular, pul-
monary, nervous, and musculoskeletal systems. Slow gait
may reflect physiological dysfunction in one or more of
these systems. Grip strength is a reliable indicator of overall
muscle strength (24), and therefore may similarly reflect
overall physiological reserve. Poor health status may result
in depressive symptoms, which may, in turn, negatively
affect patients’ self-care (including adherence with medica-
tions and follow-up appointments), creating a vicious cycle.
Because muscle weakness, slow gait, and depressive
symptoms are potentially modifiable, they should be rou-
tinely assessed in older persons with newly diagnosed heart
failure. As with other geriatric conditions, however, these
factors fall outside the conventional disease-oriented model
of clinical medicine (25); thus, they may be overlooked in
the care of older persons with newly diagnosed heart failure,
particularly when they are subtle (26–28). Modification of
physical impairments and depressive symptoms is challeng-
ing but may improve outcomes in older patients with
cardiovascular disease. Exercise training improves gait
speed, aerobic fitness, and quality of life in patients with
heart failure and may reduce the risks for hospital admission
and mortality (29,30). Recent work demonstrated that both
exercise and antidepressant treatment in depressed patients
with CAD resulted in improvement in depressive symptoms
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conditions signals a high-risk group that may benefit from
services such as nursing and pharmacy support. Whether the
assessment and management of geriatric conditions actually
improves heart failure outcomes should be examined in
future work.
The findings from the present study add valuable infor-
mation for understanding the determinants of hospital
utilization after heart failure diagnosis in older persons. The
duration of follow-up allowed a more complete assessment
of hospital admission than is available from previous heart
failure studies. Previous work that has included a similar
duration of follow-up in persons newly diagnosed with heart
failure (32) has not focused on an older population or
included information about geriatric conditions, which
emerged as important risk factors of hospital admission in
the present analyses. Detailed medical record review sup-
plemented self-reported information for several comorbid
conditions, enhancing the validity of the data. There was no
attrition for reasons other than death, further strengthening
the validity and generalizability of the results. The general-
izability of the results is also enhanced by the fact that the
CHS data were collected from a representative sample of
white and African-American community-living older per-
sons from across the United States.
Of note, the use of ACE inhibitors and beta-blockers was
not significantly associated with hospital admission. The
high prevalence of heart failure with preserved ejection
fraction in the present study sample provides one explana-
tion of this finding. Additionally, most hospital admissions
in older patients with heart failure are due to non–heart
failure related causes (32), which these medications would
not be expected to affect.
Although heart failure primarily affects older persons,
current heart failure guidelines do not incorporate routine
assessment or management of geriatric conditions. Under-
scoring the relative inattention to geriatric conditions, even
current quality indicators developed specifically for older
patients, such as the Assessing Care of Vulnerable Elders
(ACOVE) measures for heart failure, do not include the
assessment of these conditions (33). The present results
provide strong justification for developing strategies to
routinely screen for and manage these conditions at the time
of heart failure diagnosis. Through such interventions, it
may be possible to reduce the burden of hospital stays
among older persons newly diagnosed with heart failure,
thereby improving their quality of life while reducing health
care costs.
Study limitations. This study had several potential limita-
ions, which should be considered when interpreting the
esults. Data were collected beginning in 1989; heart failure
anagement has certainly changed since that time, and it is
ossible that the risk factors for hospital admission have
hanged. However, hospital admissions through 2009 were
scertained, thereby including up to 20 years of follow-up,
hich would not have been possible with a later baselinedate. Participants were censored at the time of death;
therefore, the results may have underestimated the magni-
tude of the risk associated with some strong risk factors for
both death and hospital admission (e.g., CAD), particularly
as the observed mortality rate was high (75%). Although the
presence of comorbid conditions was accounted for, it could
not be assessed whether the associations between geriatric
conditions and hospital admission were attenuated after
adjustment for severity and duration of comorbid condi-
tions. Finally, the mean age of the study participants was
79.7 years, which is certainly older than participants in-
cluded in most heart failure registries. However, the age of
the study participants was well-suited to the objective of
examining the prognostic importance of geriatric conditions
in older patients with heart failure.
Conclusions
Based on the findings from the present analysis of data from
patients with newly diagnosed heart failure, geriatric con-
ditions are important risk factors for all-cause hospital
admission; these risk factors should be routinely assessed at
the time of heart failure diagnosis.
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